Education
About Us
Working with TipRanks
Follow Us
Ramm Pharma Corp (TSE:RAMM)
:RAMM
RAMM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)21.78K
Market Cap
C$1.19M
Enterprise ValueC$692.27K
Total Cash (Recent Filing)C$745.34K
Total Debt (Recent Filing)C$43.28K
Price to Earnings (P/E)―
Beta3.47
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding119,389,320
10 Day Avg. Volume49,100
30 Day Avg. Volume21,780
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Ramm Pharma News
RAMM FAQ
What was Ramm Pharma Corp’s price range in the past 12 months?
Ramm Pharma Corp lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.
What is Ramm Pharma Corp’s market cap?
Ramm Pharma Corp’s market cap is C$1.19M.
When is Ramm Pharma Corp’s upcoming earnings report date?
Ramm Pharma Corp’s upcoming earnings report date is Feb 26, 2026 which is in 142 days.
How were Ramm Pharma Corp’s earnings last quarter?
Ramm Pharma Corp released its earnings results on Sep 27, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Ramm Pharma Corp overvalued?
According to Wall Street analysts Ramm Pharma Corp’s price is currently Overvalued.
Does Ramm Pharma Corp pay dividends?
Ramm Pharma Corp does not currently pay dividends.
What is Ramm Pharma Corp’s EPS estimate?
Ramm Pharma Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramm Pharma Corp have?
Ramm Pharma Corp has 119,389,320 shares outstanding.
What happened to Ramm Pharma Corp’s price movement after its last earnings report?
Ramm Pharma Corp reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ramm Pharma Corp?
Currently, no hedge funds are holding shares in TSE:RAMM
Company Description
Ramm Pharma Corp
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
Technical Analysis
Options Prices
Currently, No data available
---